Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children (Q40401092)

20 September 2017

title

Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children (English)

1 reference

20 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Claire Poyart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Q Vermee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

A Agathine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

A Dupuis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

E Varon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

M-C Ploy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

J Raymond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

and the ORP Ile de France Ouest

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

20 December 2016

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

20 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

831-838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Heptavalent pneumococcal conjugate vaccine: current and future impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Declining mortality from adult pneumococcal infections linked to children's vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Pneumococcal serotype evolution in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Epidemiological differences among pneumococcal serotypes

21 January 2018

1 reference

12 December 2020

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

1 reference

12 December 2020

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

1 reference

12 December 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

12 December 2020

Herd immunity and pneumococcal conjugate vaccine: a quantitative model

1 reference

12 December 2020